Patents by Inventor John GF Cleland

John GF Cleland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROGNOSIS OF ADVERSE EVENTS IN PATIENTS WITH SUSPECTED CHRONIC HEART FAILURE
    Publication number: 20170370940
    Abstract: The present invention is in the field of clinical diagnostics. Particularly the present invention relates to the prognosis of adverse events in patients with stable chronic heart failure or being suspected of having stable chronic heart failure by determination of the level of Procalcitonin (PCT).
    Type: Application
    Filed: September 1, 2017
    Publication date: December 28, 2017
    Applicant: B.R.A.H.M.S. GmbH
    Inventors: Joachim STRUCK, John GF CLELAND
  • Prognosis of adverse events in patients with suspected chronic heart failure
    Patent number: 9753039
    Abstract: The present invention is in the field of clinical diagnostics. Particularly the present invention relates to the prognosis of adverse events in patients with stable chronic heart failure or being suspected of having stable chronic heart failure by determination of the level of Procalcitonin (PCT).
    Type: Grant
    Filed: July 15, 2016
    Date of Patent: September 5, 2017
    Assignee: B.R.A.H.M.S GmbH
    Inventors: Joachim Struck, John GF Cleland
  • PROGNOSIS OF ADVERSE EVENTS IN PATIENTS WITH SUSPECTED CHRONIC HEART FAILURE
    Publication number: 20160320411
    Abstract: The present invention is in the field of clinical diagnostics. Particularly the present invention relates to the prognosis of adverse events in patients with stable chronic heart failure or being suspected of having stable chronic heart failure by determination of the level of Procalcitonin (PCT).
    Type: Application
    Filed: July 15, 2016
    Publication date: November 3, 2016
    Applicant: B.R.A.H.M.S. GmbH
    Inventors: Joachim STRUCK, John GF CLELAND
  • PROGNOSIS OF ADVERSE EVENTS IN PATIENTS WITH SUSPECTED CHRONIC HEART FAILURE
    Publication number: 20150079696
    Abstract: The present invention is in the field of clinical diagnostics. Particularly the present invention relates to the prognosis of adverse events in patients with stable chronic heart failure or being suspected of having stable chronic heart failure by determination of the level of Procalcitonin (PCT).
    Type: Application
    Filed: April 11, 2013
    Publication date: March 19, 2015
    Applicant: B.R.A.H.M.S. GmbH
    Inventors: Joachim Struck, John GF Cleland